Noninvasive monitoring of glucose levels: Is exhaled breath the answer?

Journal of Diabetes Science and Technology

Volumn 6, Issue 3, 2012, Pages 659-664

  Roberts, Kiera ^a   Jafe, Adam ^a,b   Verge, Charles ^a,b   Thomas, Paul S ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; BIOLOGICAL MARKER;

ABSORPTION SPECTROSCOPY; ANION EXCHANGE CHROMATOGRAPHY; BLOOD GLUCOSE MONITORING; BODY FLUID; BREATH ANALYSIS; CYSTIC FIBROSIS; DIABETES MELLITUS; ELECTRONIC NOSE; EPITHELIUM CELL; EXHALATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; INFRARED SPECTROSCOPY; LUNG INTERSTITIUM; MASS SPECTROMETRY; NON INVASIVE PROCEDURE; RESPIRATORY FLUID; REVIEW; SELF MONITORING; ANIMAL; BLOOD; METABOLISM; METHODOLOGY; PREDICTIVE VALUE; PROGNOSIS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BREATH TESTS; CYSTIC FIBROSIS; DIABETES MELLITUS; EXHALATION; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84879697142     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600322     Document Type: Review

References (42)

1. Australian Institute of Health and Welfare. Incidence of type 1 diabetes in Australian children 2000-2008. Diabetes series no. 13. Cat. no. CVD 51. Canberra (Australia): AIHW; 2010.
2. Shaw J. Epidemiology of childhood type 2 diabetes and obesity. Pediatr Diabetes. 2007;8(Suppl 9):7-15. (Pubitemid 350066643)
3. Olds TS, Tomkinson GR, Ferrar KE, Maher CA. Trends in the prevalence of childhood overweight and obesity in Australia between 1985 and 2008. Int J Obesity (Lond). 2009;34(1):57-66.
4. Van Dieren S, Beulens J, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(Suppl 1):S3-8.
5. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988;112(3):373-377. (Pubitemid 18079818)
6. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care. 2010;33(Suppl 1):S11-61.
7. Hameed S, Morton JR, Jafé A, Field PI, Belessis Y, Yoong T, Katz T, Verge CF. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care. 2010;33(2):221-6.
8. Brennan AL, Geddes DM, Gyi KM, Baker EH. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros. 2004;3(4):209-22. (Pubitemid 40227489)
9. Hansen M, Pedersen-Bjergaard U, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Pramming S, Thorsteinsson B. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract. 2009;85(2):183-8.
10. Klonof DC. A review of continuous glucose monitoring technology. Diabetes Technol Ther. 2005;7(5):770-5.
11. Dillon EL, Janghorbani M, Angel JA, Casperson SL, Grady JJ, Urban RJ, Volpi E, Shefield-Moore M. Novel noninvasive breath test method for screening individuals at risk for diabetes. Diabetes Care. 2009;32(3):430-5.
12. Hands C, Round J, Thomas J. "When someone stabs you": children's perspectives of venepuncture. Arch Dis Child. 2009;94(6):466.
13. Mollema E, Snoek FJ, Adèr HJ, Heine RJ, van der Ploeg HM. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res. 2001;51(5):665-72. (Pubitemid 34007445)
14. Pickup JC, Hussain F, Evans ND, Sachedina N. In vivo glucose monitoring: the clinical reality and the promise. Biosens Bioelectron. 2005;20(10):1897-902. (Pubitemid 40312083)
15. Oliver NS, Toumazou C, Cass AE, Johnston DG. Glucose sensors: a review of current and emerging technology. Diabet Med. 2009;26(3):197-210.
16. Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther. 2009;11(Suppl 1):S11-6.
17. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52(11):2790-4. (Pubitemid 37339709)
18. Ferrante do Amaral CE, Wolf B. Current development in non-invasive glucose monitoring. Med Eng Phys. 2008;30(5):541-9. (Pubitemid 351749846)
19. McGarraugh G. The chemistry of commercial continuous glucose monitors. Diabetes Technol Ther. 2009;11(Suppl 1):17-24.
20. Saraoglu HM, Kocan M. Determination of blood glucose level-based breath analysis by a quartz crystal microbalance sensor array. IEEE Sensors J. 2010;10(1):104-9.
21. Minh TDC, Oliver SR, Ngo J, Flores R, Midyett J, Meinardi S, Carlson MK, Rowland FS, Blake DR, Galassetti PR. Noninvasive measurement of plasma glucose from exhaled breath in healthy and type 1 diabetic subjects. Am J Physiol Endocrinol Metab. 2011;300(6):E1166-75.
22. Popov TA. Human exhaled breath analysis. Ann Allergy Asthma Immunol. 2011;106(6):451-6.
23. Turner C, Spanel P, Smith D. A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry, SIFT-MS. Physiol Meas. 2006;27(4):321-37.
24. Smith D, Spanìl P, Fryer AA, Hanna F, Ferns GA. Can volatile compounds in exhaled breath be used to monitor control in diabetes mellitus? J Breath Res. 2011;5(2):022001.
25. Rosias PP, Dompeling E, Hendriks HJ, Heijnens JW, Donckerwolcke RA, Jöbsis Q. Exhaled breath condensate in children: pearls and pitfalls. Pediatr Allergy Immunol. 2004;15(1):4-19. (Pubitemid 38327294)
26. Horváth I, Hunt J, Barnes PJ; ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26(3):523-48. (Pubitemid 41264218)
27. Jöbsis Q, Raatgeep HC, Schellekens SL, Hop WC, Hermans PW, de Jongste JC. Hydrogen peroxide in exhaled air of healthy children: reference values. Eur Respir J. 1998;12(2):483-5. (Pubitemid 28389550)
28. Baraldi E, Ghiro L, Piovan V, Carraro S, Zacchello F, Zanconato S. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child. 2003;88(4):358-60. (Pubitemid 36398984)
29. Bodini A, D'Orazio C, Peroni D, Corradi M, Folesani G, Baraldi E, Assael BM, Boner A, Piacentini GL. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections. Pediatr Pulmonol. 2005;40(6):494-9. (Pubitemid 41720705)
30. Carpagnano G, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med. 2003;167(8):1109-12. (Pubitemid 36459657)
31. Ratnawati J, Henry R, Thomas P. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol. 2006;41(10):929-36. (Pubitemid 44534810)
32. Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol. 2009;4(2):172-8.
33. Baker EH, Clark N, Brennan AL, Fisher DA, Gyi KM, Hodson ME, Philips BJ, Baines DL, Wood DM. Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. J Appl Physiol. 2007;102(5):1969-75. (Pubitemid 46701969)
34. Saumon G, Martet G, Loiseau P. Glucose transport and equilibrium across alveolar-airway barrier of rat. Am J Physiol. 1996;270(2 Pt 1):L183-90.
35. De Prost N, Saumon G. Glucose transport in the lung and its role in liquid movement. Respir Physiol Neurobiol. 2007;159(3):331-7. (Pubitemid 350123609)
36. Pezzulo AA, Gutierrez J, Salm KS, McConnell KS, Karp P, Stoltz DA, Zabner J. Airway epithelia regulate airway surface liquid glucose concentration. FASEB J. 2009;23(Meeting Abstract Supplement):570.3
37. Philips BJ, Redman J, Brennan A, Wood D, Holliman R, Baines D, Baker EH. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax. 2005;60(9):761-4. (Pubitemid 41297896)
38. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, Jones PW. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284-9.
39. Philips BJ, Meguer JX, Redman J, Baker EH. Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med. 2003;29(12):2204-10. (Pubitemid 38030673)
40. Wood DM, Brennan AL, Philips BJ, Baker EH. Efect of hyperglycaemia on glucose concentration of human nasal secretions. Clin Sci (Lond). 2004;106(5):527-33. (Pubitemid 38639557)
41. Srivastava S, Gyi KM, Hodson ME, Baker EH. Repeat measurements of breath glucose and breath to blood glucose ratio in adult patients with cystic fibrosis. Thorax. 2008;63(Suppl 7):A96-7.
42. Srivastava S, Nguyen T, Burgess J, Bilton D, Hodson M, Gyi K, Baker E. Breath glucose as a marker of pulmonary inflammation in adult patients with cystic fibrosis. 24th Annual North American Cystic Fibrosis Conference; 2010 Oct 21-23; Baltimore (MD). 2010. (Abstract)375-375.